CarsonAllaria Wealth Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-150
Closed -$441 355
2024
Q3
$441 Hold
150
﹤0.01% 380
2024
Q2
$522 Hold
150
﹤0.01% 362
2024
Q1
$428 Hold
150
﹤0.01% 381
2023
Q4
$530 Hold
150
﹤0.01% 342
2023
Q3
$389 Hold
150
﹤0.01% 352
2023
Q2
$591 Hold
150
﹤0.01% 371
2023
Q1
$507 Hold
150
﹤0.01% 356
2022
Q4
$1K Hold
150
﹤0.01% 305
2022
Q3
$1K Hold
150
﹤0.01% 304
2022
Q2
$1K Hold
150
﹤0.01% 300
2022
Q1
$1K Buy
+150
New +$1.05K ﹤0.01% 312

Other funds holding SRTA

CarsonAllaria Wealth Management's SRTA Position: Q4 2024 in Review

CarsonAllaria Wealth Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2024, closing a stake of 150 shares — an estimated $441 sold.

CarsonAllaria Wealth Management first reported a position in SRTA in Q1 2022 and held it in 11 quarters. The position peaked at $1K in Q4 2022. 122 funds tracked by Wall St. Rank hold SRTA as of Q4 2024.

  • CarsonAllaria Wealth Management reported no remaining Strata Critical Medical Inc position as of Q4 2024 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 150 Strata Critical Medical Inc shares in Q4 2024, an estimated $441.
  • CarsonAllaria Wealth Management first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 11 quarters.
  • CarsonAllaria Wealth Management's Strata Critical Medical Inc position peaked at $1K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2024.

Based on CarsonAllaria Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.